Latest Breaking News On - For registrant - Page 1 : comparemela.com

Supernus Pharmaceuticals : 2023 Annual Report

Dear Supernus Stockholder, We are very pleased with our performance in 2023 as we continued to successfully transition from our mature brands and set the stage to.

Lineage Cell Therapeutics : Annual report which provides a comprehensive overview of the company for the past year -March 10, 2024 at 04:43 am EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K .

Form 10-K John Deere Owner Trust For: Oct 29

Form 10-K/A Data443 Risk Mitigation, For: Dec 31

Form 10-KT Agentix Corp. For: Mar 31